Skip to main
GLYC
GLYC logo

GlycoMimetics (GLYC)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy GlycoMimetics (GLYC) Stock

About GlycoMimetics (GLYC)

GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Market cap$1.01B
Today's volume15.68K
Revenue (TTM)
Avg. daily volume18.35K
EBITDA (TTM)-$23.77M
Open$13.75
Price / earnings ratio-34.34x
Today's range$14.91 - $19.32
Debt / equity
52 week range$14.06 - $63
5 year debt / equity0.56x
Beta (LTM)1.41x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio2.29x
Ex-dividend date
Next earningsAug 8, 2025
Dividend payable date

GlycoMimetics Stock Rating

What analysts recommend for GLYC stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for GLYC stock is $1.02B

The current P/E ratio for GLYC stock is -34.34

The 52-week high for GLYC stock is $63. The current GLYC stock price $undefined is 100.00% below its 52-week high

The 52-week low for GLYC stock is $14.06. The current GLYC stock price $undefined has increased 100.00% from its 52-week low

No, the GLYC stock does not pay dividends to its shareholders

The target price for GLYC stock is $11.25 based on the average of what a group of analyst think GLYC stock could be worth at a future date. This is not a prediction by Public.com

How to buy GLYC stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GLYC stock

    Navigate to the Explore page. Then, type GLYC into the search bar. When you see GLYC stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GLYC stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

GlycoMimetics Stock Earnings

The value each GLYC share was expected to gain vs. the value that each GLYC share actually gained.

GlycoMimetics (GLYC) reported Q4 2024 earnings per share (EPS) of -$0.11, missing estimates of -$0.07 by 57.14%. In the same quarter last year, GlycoMimetics's earnings per share (EPS) was -$0.14. GlycoMimetics is expected to release next earnings on 08/08/2025, with an earnings per share (EPS) estimate of $0.

Buy GlycoMimetics (GLYC) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.